Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hasselt, B. van"'
Autor:
Steen, W. van der, Graaf, R.A.V. de, Chalos, V., Lingsma, H.F., Doormaal, P.J. van, Coutinho, J.M., Emmer, B.J., Ridder, I. de, Zwam, W. van, Worp, H.B. van der, Schaaf, I. van der, Gons, R.A.R., Yo, L.S.F., Boiten, J., Wijngaard, I. van den, Hofmeijer, J., Martens, J., Schonewille, W., Vos, J.A., Tuladhar, A.M., Laat, K.F. de, Hasselt, B. van, Remmers, M., Vos, D., Rozeman, A., Elgersma, O., Uyttenboogaart, M., Bokkers, R.P.H., Tuijl, J. van, Boukrab, I., Berg, R. van den, Beenen, L.F.M., Roosendaal, S.D., Postma, A.A., Krietemeijer, M., Lycklama, G., Meijer, F.J.A., Hammer, S., Hoorn, A. van der, Yoo, A.J., Gerrits, D., Truijman, M.T.B., Zinkstok, S., Koudstaal, P.J., Manschot, S., Kerkhoff, H., Nieboer, D., Berkhemer, O., Wolff, L., Sluijs, P.M. van der, Voorst, H. van, Tolhuisen, M., Roos, Y.B.W.E.M., Majoie, C.B.L.M., Staals, J., Oostenbrugge, R.J. van, Jenniskens, S.F.M., Dijk, L.C. van, Hertog, H.M. den, Es, A.C.G.M. van, Lugt, A. van der, Dippel, D.W.J., Roozenbeek, B., MR CLEAN-MED Investigators
Publikováno v:
MR CLEAN-MED Investigators 2022, ' Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED) : an open-label, multicentre, randomised controlled trial ', The Lancet, vol. 399, no. 10329, pp. 1059-1069 . https://doi.org/10.1016/S0140-6736(22)00014-9
The Lancet, 399(10329), 1059-1069. ELSEVIER SCIENCE INC
The Lancet (London), 399, 1059-1069
The Lancet, 399(10329), 1059-1069. Elsevier Limited
The Lancet, 399(10329), 1059-1069. Elsevier Ltd.
The Lancet (London), 399, 10329, pp. 1059-1069
Lancet, 399(10329), 1059-1069. Elsevier Science
The Lancet, 399(10329), 1059-1069. ELSEVIER SCIENCE INC
The Lancet (London), 399, 1059-1069
The Lancet, 399(10329), 1059-1069. Elsevier Limited
The Lancet, 399(10329), 1059-1069. Elsevier Ltd.
The Lancet (London), 399, 10329, pp. 1059-1069
Lancet, 399(10329), 1059-1069. Elsevier Science
BACKGROUND: Aspirin and unfractionated heparin are often used during endovascular stroke treatment to improve reperfusion and outcomes. However, the effects and risks of anti-thrombotics for this indication are unknown. We therefore aimed to assess t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8953cfdde4fc4e0b25a24d129984fa64
https://research.vumc.nl/en/publications/155f1e87-ba12-4257-8269-1662795d2460
https://research.vumc.nl/en/publications/155f1e87-ba12-4257-8269-1662795d2460
Autor:
Samuels, N., Graaf, R.A. van de, Berg, C.A.T. van den, Nieboer, D., Eralp, I., Treurniet, K.M., Emmer, B.J., Immink, R.V., Majoie, C., Zwam, W.H. van, Bokkers, R.P., Uyttenboogaart, M., Hasselt, B. van, Muhling, J., Burke, J.F., Roozenbeek, B., Lugt, A. van der, Dippel, D.W., Jenniskens, S.F.M., Boogaarts, H.D., Dijk, E.J. van, Lingsma, H.F., Es, A. van
Publikováno v:
Neurology, 96(2), e171-e181. Lippincott Williams and Wilkins
Neurology, 96, 2, pp. e171-e181
Neurology, 96(2), e171-e181. LIPPINCOTT WILLIAMS & WILKINS
Neurology, 96, e171-e181
Neurology, 96(2), E171-E181. LIPPINCOTT WILLIAMS & WILKINS
Neurology
Neurology, 96(2), e171-e181. Lippincott Williams & Wilkins
article-version (Version of Record) 3
UnpayWall
Microsoft Academic Graph
Sygma
Neurology, 96, 2, pp. e171-e181
Neurology, 96(2), e171-e181. LIPPINCOTT WILLIAMS & WILKINS
Neurology, 96, e171-e181
Neurology, 96(2), E171-E181. LIPPINCOTT WILLIAMS & WILKINS
Neurology
Neurology, 96(2), e171-e181. Lippincott Williams & Wilkins
article-version (Version of Record) 3
UnpayWall
Microsoft Academic Graph
Sygma
ObjectiveTo evaluate the role of blood pressure as mediator of the effect of conscious sedation (CS) compared to local anesthesia (LA) on functional outcome after EVT.MethodsPatients treated in MR CLEAN Registry centers with CS or LA as preferred ane
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0067e886f6975192cfbb34dba0fc642
https://hdl.handle.net/1887/3512783
https://hdl.handle.net/1887/3512783
Autor:
Graaf, R.A. van de, Chalos, V., Es, A.C.G.M. van, Emmer, B.J., Nijeholt, G.J.L.A., Worp, H.B. van der, Schonewille, W.J., Lugt, A. van der, Dippel, D.W.J., Lingsma, H.F., Roozenbeek, B., Dippel, D., Majoie, C., Roos, Y., Oostenbrugge, R. van, Zwam, W. van, Boiten, J., Vos, J.A., Jansen, I., Mulder, M., Goldhoorn, R.J., Compagne, K., Kappelhof, M., Schonewille, W., Coutinho, J., Wermer, M., Walderveen, M. van, Staals, J., Hofmeijer, J., Martens, J.M., Nijeholt, G.L.A., Emmer, B., Bruijn, S. de, Dijk, L. van, R. lo, Dijk, E. van, Boogaarts, H., Kort, P. de, Peluso, J., Berg, J. van den, Hasselt, B. van, Aerden, L., Dallinga, R., Uyttenboogaart, M., Eshghi, O., Schreuder, T., Heijboer, R., Keizer, K., Yo, L., Hertog, H. den, Sturm, E., Sprengers, M., Jenniskens, S., Berg, R. van den, Yoo, A., Beenen, L., Postma, A., Roosendaal, S., Kallen, B. van der, Wijngaard, I. van den, Es, A. van, Martens, J., Bot, J., Doormaal, P.J. van, Worp, B. van der, Flach, Z., Lingsma, H., Ghannouti, N. el, Sterrenberg, M., Puppels, C., Pellikaan, W., Sprengers, R., Elfrink, M., Meris, J. de, Vermeulen, T., Geerlings, A., Vemde, G. van, Simons, T., Rijswijk, C. van, Messchendorp, G., Bongenaar, H., Bodde, K., Kleijn, S., Lodico, J., Droste, H., Wollaert, M., Jeurrissen, D., Bos, E., Drabbe, Y., Aaldering, N., Zweedijk, B., Khalilzada, M., Venema, E., Geuskens, R., Straaten, T. van, Ergezen, S., Harmsma, R., Muijres, D., Jong, A. de, Hinseveld, W., Berkhemer, O., Boers, A., Huguet, J., Groot, P., Mens, M., Kranendonk, K. van, Treurniet, K., Tolhuijsen, M., Alves, H., MR CLEAN Registry Investigators
Publikováno v:
Stroke, 50(8), 2147-2155. Lippincott Williams and Wilkins
Stroke, 50(8), 2147-2155. LIPPINCOTT WILLIAMS & WILKINS
Stroke
Journal of the American Heart Association, 50(8), 2147-2155. Wiley
MR CLEAN Registry Investigators 2019, ' Periprocedural Intravenous Heparin During Endovascular Treatment for Ischemic Stroke: Results From the MR CLEAN Registry ', Stroke, vol. 50, no. 8, pp. 2147-2155 . https://doi.org/10.1161/STROKEAHA.119.025329
Stroke, 50, 8, pp. 2147-2155
Stroke; a journal of cerebral circulation, 50(8), 2147-2155. Lippincott Williams and Wilkins
Stroke, 50, 2147-2155
Stroke, 50(8), 2147-2155
Stroke, 50(8), 2147-2155. LIPPINCOTT WILLIAMS & WILKINS
Stroke
Journal of the American Heart Association, 50(8), 2147-2155. Wiley
MR CLEAN Registry Investigators 2019, ' Periprocedural Intravenous Heparin During Endovascular Treatment for Ischemic Stroke: Results From the MR CLEAN Registry ', Stroke, vol. 50, no. 8, pp. 2147-2155 . https://doi.org/10.1161/STROKEAHA.119.025329
Stroke, 50, 8, pp. 2147-2155
Stroke; a journal of cerebral circulation, 50(8), 2147-2155. Lippincott Williams and Wilkins
Stroke, 50, 2147-2155
Stroke, 50(8), 2147-2155
Supplemental Digital Content is available in the text.
Background and Purpose— Intravenous administration of heparin during endovascular treatment for ischemic stroke may improve outcomes. However, risks and benefits of this adjunctive therapy
Background and Purpose— Intravenous administration of heparin during endovascular treatment for ischemic stroke may improve outcomes. However, risks and benefits of this adjunctive therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd7fc951ed84216fc3d4048da797ce58
https://research.vumc.nl/en/publications/85888a36-7e45-414a-86e0-f32b431de225
https://research.vumc.nl/en/publications/85888a36-7e45-414a-86e0-f32b431de225